Tell us who you want to see featured on the list – and why, using the link below. We are counting on you to nominate your collaborators, colleagues and peers.
The Medicine Maker speaks with Dr. Martin Klatt, Director Sales Pharma Solutions Europe from BASF
The color of a capsule or tablet can have a big impact on compliance and branding. To avoid delays, early decisions have to be made.
The Medicine Maker speaks with Jeanne Thoma, President and CEO from SPI Pharma
In 2018, the UK’s government appointed its first Minister for Loneliness. The role: to tackle loneliness.
With so much technology at our disposal, it’s time to get smart in formulation by adopting in silico approaches.
The UK’s Centre for Process Innovation targets easier manufacturing of nanoformulated medicines.
Beatriz Domínguez and Ahir Pushpanath
Enzyme engineering has opened up new possibilities in biocatalysis, but computational techniques and smart libraries also make wildtypes feasible. The choice is yours.
Why we shouldn’t forget gelatin’s longstanding reputation as a reliable and trusted excipient.
The end of “mini me” medicine is over, says Andrew Parker, because we can do better when it comes to pediatric care.
Products are becoming increasingly complex and we need to get better at recognizing the strategies with the best advantages.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.